Breast Cancer Clinical Trials

Showing 201-220 of 5,597 trials

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

NCT05534438

The purpose of this study is to see if using Stereotactic Body Radiation Therapy/SBRT to treat a single metastatic site where cancer has worsened may be an effective treatment for people with oligometastatic breast cancer. Participants will stay on their usual drug therapy while they receive SBRT. This combination of SBRT to a single metastatic site and usual drug therapy may prevent participants' cancer from worsening in other metastatic sites or spreading.

Oligometastatic Breast CarcinomaBreast CancerMetastatic Breast Cancer+3 more

Memorial Sloan Kettering Cancer Center46 participantsStarted Sep 2022

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Montvale, New Jersey, United States +5 more locations

RECRUITINGPhase 3

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

NCT07085767

This phase 3 clinical trial compares the efficacy and safety of palazestrant with ribociclib to letrozole and ribociclib in women and men who have not received prior systemic anti-cancer treatment for advanced breast cancer.

Breast CancerLocally Advanced Breast CancerMetastatic Breast Cancer+2 more

Olema Pharmaceuticals, Inc.1,000 participantsStarted Nov 2025

Hot Springs, Arkansas, United States • Santa Barbara, California, United States • Denver, Colorado, United States +82 more locations

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Related Searches

FUSCC Refractory TNBC Platform Study (FUTURE2.0)

Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families

Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment

Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.

Agnostic Therapy in Rare Solid Tumors

Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer

Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer

Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted Therapy

A Study of XMT-1660 in Participants With Solid Tumors

Managed Access Programs for BYL719, Alpelisib

Feasibility of 'Exercise for CAncer Patients and Healthy EAting Timeframes' .

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer

Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer